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genotypes in four districts show a signiﬁcantly different
distribution, Peshawar (P= 0.041), Charsadda (P= 0.015),
Mardan (P= 0.05), Sawabi (P= 0.040) and non signiﬁcant
in Nowshehra district (P= 0.06). Among the risk factors,
use of unsterile equipments for medication, barbers and
previous history of hospitalization are the main factors for
HCV transmission. Genotype 3a and 3b, 1a, 1b and 2a are
the common genotypes in North West Frontier Province.
Genotype 4, 5, and 6 were not found even in a single
sample.
There is a less awareness about the various mode of
transmission of HCV among the population. A predominant
number of them are considering interferon treatment as
vaccine for hepatitis B and C.
PP-134 Fibrosure, APRI and Forns score versus liver
biopsy in chronic HCV infection in Egypt
H. Abd El Moety1 *, A.M.R. Abd El Moety2, S. Zaki3,
S. Baioumy4. 1Chemical Pathology, Medical Research
Institute, Alexandria University, 2Internal Medicine,
Faculty of Medicine, Alexandria University, 3Microbiology,
Faculty of Medicine, Alexandria University, 4Pathology,
Tanta University, Egypt
Introduction: Chronic infection with HCV a major health
problem. Clinical management of chronic HCV dependent
on extent liver ﬁbrosis. Liver biopsy gold stander an
invasive procedure responsible for severe complications
and sample variability interpretation. Serum biomarkers for
inﬂammation/ﬁbrosis investigated to wave liver biopsy.
Aim: Diagnostic accuracy panel of Non-invasive serum
biomarkers for hepatic ﬁbrosis [Fibrosure, APRI score, Forn’s
score] versus liver biopsy.
Method: 20 HCV patients subjected for: APRI, Forn’s,
Fibrosure scores; PCR quantitative HCV-RNA; liver functions;
lipid proﬁle; CBC; ultrasound guided liver biopsy.
Results:
FORNS score; AUROC (0.917) with 95% CI (0.791 1.042)
for (fof1) vs. (f2f3f4) while (0.688) with 95% CI (0.464 0.91)
for (fof1f2) vs. (f3f4). Cutoff (>6.9) sensitivity for
signiﬁcant ﬁbrosis (f2f3f4) and extensive ﬁbrosis (f3f4)
were (100%) speciﬁcity (0%) with accuracy (40%) and (20%)
respectively.
APRI score; AUROC (0.792) with 95% CI (0.568 1.015)
comparing (f0f1) vs. (f2f3f4) while was (0.875) with 95%
CI (0.703 1.047) for (f0f1f2) vs. (f3f4). Cutoff (<0.5)
sensitivity (0%) and speciﬁcity (100%) with accuracy (60%)
for signiﬁcant ﬁbrosis and (80%) for extensive ﬁbrosis.
Fibrosure (ﬁbro-acti test); showed best AUROC (1.00) in
different ﬁbrotic stages with 95% CI (1.00 1.00). Cutoff
(>0.59) sensitivity (50%) for signiﬁcant ﬁbrosis and (100%)
for extensive ﬁbrosis while speciﬁcity (100%) in all ﬁbrotic
stages. The PPV (100%) for signiﬁcant and extensive
ﬁbrosis. NPV and accuracy (75%, 80%) respectively for
signiﬁcant ﬁbroses, while NPV and accuracy (100%) for
extensive ﬁbrosis.
Signiﬁcant correlation between liver biopsy and Fibro-test
(P 0.002) and Acti-test (P 0.000).
Signiﬁcant correlation between liver biopsy hepatitis
activity score andAPRI (P 0.047) and FORNS score (P 0.000).
Conclusion: FORNS score wasn’t considered since does not
discriminate between signiﬁcant and extensive ﬁbrosis. Low
sensitivity of APRI prohibtes detection of minmal ﬁbrosis
and allow undetermined results. Fibrosure classiﬁed all
cases of chronic HCV sufﬁcient to waive liver biopsy.
PP-135 Discovery of the missed link between
schistosomiasis and HCV infection
H. Abd El Moety1, A. Abd El Moety2 *, S. Zaki3, A.M.R. Abd El
Moety2. 1Chemical Pathology, Medical Research Institute,
Alexandria University, 2Internal Medicine, Faculty of
Medicine, Alexandria University, 3Microbiology, Faculty of
Medicine, Alexandria University, Egypt
Schistosomiasis is a term covering infestation of man by
blood ﬂuke trematode parasite. In Egypt, Schistosoma
mansoni occurs intensively in the Nile Delta, while
S. hematobium is endemic in Nile Valley. Studies in Egypt
found the highest risk of HCV infection in those infested
with schistosomiasis. HCV-Ab prevalence reported 70% in
adults suffering from Schistosomiasis and without history of
blood transfusion.
Aim: Determine the link between schistosomal infestation
and HCV, whether the parasite could be vector of
transmission of the virus to human.
Methods: Different stages of life cycle of S. mansoni
provided by Theodor Bilharz Institute.
Specimens of living S. mansoni worms and Biomphalaria
alexandria snails were grounded separately in sterile mortar
after adding 5ml sterile saline. After centrifugation sterile
supernatant tested for
• Detection of HCV-RNA by RT-PCR
• HCV-RNA quantitation.
Results:
• HCV-Antigen: Worms, Miracidia, Snails and Cercariae of
S. mansoni were positive for HCV-Ag. The snails gave
strong positive result. Eggs gave negative result.
• HCV-RNA by RT-PCR: Worms, Miracidia, Snails and
Cercariae of S. mansoni tested for HCV-RNA By Qualitative
RT-PCR were positive. The eggs gave negative result.
• HCV-RNA Quantitation: Miracidia were positive (800
copies/ml) and snails were positive (1100 copies/ml);
other specimens gave negative results.
Conclusions:
• Existence of virus and its replication in parasite
• S. mansoni parasite carries HCV and considered as a non-
human vector for transmission of HCV infection.
• Parasitic and viral co-infection change pathology of
hepatic schistosomiasis from periportal ﬁbrosis to cirrhosis
and the development of HCC.
PP-136 Comparison study of DFPP plus IFN and
ribavirin combination therapy for genotype 1b
HCV patients with high HCVRNA load
L. Peng1 *, J. Liu1, J.-G. Li1. 1Department of Infectious
Diseases, 3rd Afﬁliated Hospital of SunYat-sen University,
China
Background: Some genotype 1b HCV patients with high
HCVRNA load can not get satisfactory anti-virus response.
DFPP (double ﬁltration plasmapheresis) is a newly developed
biotechnology technique which can selectively removes high
molecular weight substances including HCV particles from
plasma. In this study, efﬁcacy and safety of DFPP plus anti-
virus therapy were studied and compared in treatment of
HCV patients.
Methods: 8 chronic genotype 1b HCV patients received
anti-virus therapy (IFN and ribavirin) at 8th day after
admission and each of them individually decided whether
to receive DFPP therapy. Then 8 weeks of observation were
performed.
Result: Only 1 patient decided to receive 5 times of DFPP
therapy (at 8th, 9th, 11th, 15th and 16st day after admission)
with anti-virus therapy and got satisfactory response at 29rd
day with liver function improving. Other patients did not
get the same satisfactory responses. HCVRNA degression
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could be observed after every DFPP therapies and negative-
detected at exit of separator. No adverse events were
observed in all patients.
Conclusion: DFPP plus antivirus drug therapy is safe and
effective treatment for genotype 1b HCV patients with high
HCVRNA load.
Figure: Comparison of HCVRNA load degression. Patient 1
received DFPP plus IFN and ribavirin combination therapy.
HCV RNA (IU/ml) changings before and after every times of DFPP
(HCV RNA were <1000 IU/ml at 13th days after the 5th DFPP)
Time of DFPP HCV RNA
before DFPP afterDFPP intramembrane extramembrane
1st 3.47E+07 2.27E+07 2.68E+07 <e3
2nd 1.99E+06 1.57E+06 2.55E+06 <e3
3rd 2.48E+05 1.39E+05 3.12E+05 <e3
4th 4.42E+04 3.96E+04 2.56E+04 <e3
5th 2.21E+05 1.94E+05 2.45E+05 <e3
PP-137 Isolation of Ag_AB complex for detection of HCV
Core antigen using ELISA method
S. Nourollahi1 *, M. Boutorabi2, A. Mirjalili3, M. Razaghi2,
M. Hashemi4. 1Zanjan Azad University, 2Pishtaz Teb
Company, 3Razi Vaccine and Serum Research Institute,
4Payamenour University of Tehran, Iran
Studies show that during ﬁrst days of infection with hepatitis
type C virus, core antigen will appear more quickly than
antibody against the virus. Therefore detecting core antigen
is a useful index for diagnosing infection.
In order to exclude the probable effect of antibody presence
against the Core antigen, the positive antibody serum
samples were treated by different solutions, including 1.5M
glycine buffer with pH = 2, 0.5 Normal chloridic acid, and
triton X-100 with 0.1% concentration.
Titration of antibodies present in the serums which were
treated by acid had shown a considerable decrease.
Nonetheless, no such titration decrease was observed
in samples treated to triton X-100. Antibody titration
had a substantial decrease after adjacency treatment to
with acidic solutions in samples with negative antigen
and positive PCR results with veriﬁed antibody presence.
Regarding the comparison of light absorbance of samples
with positive PCR and negative antigen results, adjacency
to glycine buffer (pH = 2) for one hour in 37oC resulted in
more increase in light absorbance than treatment with
normal chloridric acid in 37oC. One the other hand,
this indicates that increase in light absorbance in the
samples with positive antibody after adjacency treatment
with acidic solution for testing the antigen is a speciﬁc
phenomenon caused by separation of antibody from antigen
and subsequent identiﬁcation of Core antigen via this
evaluation technique.
Sensitivity of the test before and after adjacency treatment
of serum with 1.5M glycine solution was 57.3 and
88 percent, respectively, which indicates its favorite
sensitivity and speciﬁcity among studies so far.
The increase in test sensitivity subsequent to adjacency
to 1.5M glycine buffer indicates the elimination of
interference of antibodies presence against Core antigen
in serum.
PP-138 Correlations of plasma lipid level with serum
hepatitis C virus RNA and liver histopathological
steatosis in patients with chronic hepatitis C
Y.-R. Li1 *, W. Ling1, F.-X. Chen1, X.-L. Fan1. 1Beijing Ditan
Hospital, Beijing, China
Objectives: To investigate the relationship among plasma
lipid level, serum hepatitis C virus RNA load, and liver
histological steatosis in patients with chronic hepatitis C.
Methods: Fluorescent quantitative polymerase chain
reaction was used to detect the load of serum HCVRNA in 75
patients with chronic hepatitis C; The levels of plasma TG,
CHO, LDL, HDL, ApoA, ApoB were measured by biochemical
instrument. Liver biopsy was performed in 62 of 75 patients,
and histopathological changes were observed by HE staining
under light microscope and scored according to the grades
of liver necro-inﬂammatory activity, stages of liver ﬁbrosis
and liver steatosis.
Results: There were differences signiﬁcantly in the
levels of LDL, ApoB among the three groups (HCVRNA
<105copies/ml; 105 107 copies/ml; and >107copies/ml).
There were differences signiﬁcantly in HCVRNA load among
three groups depending on different liver steatosis. The
load of HCVRNA was positively correlated with that of LDL,
ApoB (r = 0.305, 0.417; P= 0.011, 0.001). 67.7% of CHC
patients had liver steatosis.
Conclusion: The levels of plasma LDL and ApoB were related
to the load of HCV rather than the degrees of liver injury
and ﬁbrosis.
PP-139 Efﬁcacy of treatment with interferon
alfa/ribavirin of patients with chronic viral
hepatitis C in relation to GNB3 polymorphism
L. Ziyakhanova1 *, E. Musabaev1, M. Abdukadirova1,
A. Khikmatullaeva1. 1Institute of Virology, Tashkent,
Uzbekistan
The insufﬁcient efﬁcacy of ethiotropic therapy in some
patients constantly interest of specialists for research of
the causes of different virological response to treatment of
the patients infected with HCV virus. In spite of this fact
that therapeutic response in patients with HCV is rather
dependent on virus genotype there are human genetic
factors giving therapeutic effect in patients infected with
genotype 1 HCV.
According to the data of some investigations (Sarrazin Ch
et al., 2005 and others) polymorphisms of some genes are
genetic markers of T-cellular immune response and induce
reduction of functional ability of immune cells in response
to some chemokines that indicates about possible link of the
response to antiviral therapy viral hepatitis C with genotype
of some genes. The blood samples for determination of
genotypes of viral hepatitis C and selection of the samples
for determination of C825T gene GNB3 were obtained from
60 patients with viral hepatitis C. The investigation includes
40 HCV positive patients with chronic hepatitis C who
received treatment with pegilated interferon alpha-2a in
combination with ribavirin during more than 24 weeks
and 20 patients without antiviral therapy. Control group
comprised of blood samples from 20 healthy subjects.
Diagnosis was based on the clinical picture of disease
during not less than 6 months of observation, increased
